ORALHEP
DEAD

Serial Number

79036480

Owner

ENDOTIS PHARMA

Attorney

William C. Wright

Filing Date

Jan 24, 2007

Add to watchlist:

No watchlists yet
View on USPTO

ORALHEP Trademark

Serial Number: 79036480

ORALHEP is a trademark filed by ENDOTIS PHARMA on January 24, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ENDOTIS PHARMA (2 trademarks)

Parc Eurasante -

Entity Type: 99

Trademark Details

Filing Date

January 24, 2007

Registration Date

Not Registered

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 9, 2008 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 9, 2008 OPNR
ASSIGNED TO LIE
Jun 20, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
May 23, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 23, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
May 23, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 23, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 19, 2008 ZZZX
DEATH OF INTERNATIONAL REGISTRATION
May 8, 2008 DETH
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 17, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 2, 2008 PREV
ASSIGNED TO LIE
Mar 2, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2008 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 20, 2007 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 20, 2007 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 20, 2007 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2007 TROA
REFUSAL PROCESSED BY IB
Jun 8, 2007 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2007 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2007 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 22, 2007 RFCR
NON-FINAL ACTION WRITTEN
May 21, 2007 CNRT
ASSIGNED TO EXAMINER
May 11, 2007 DOCK
NEW APPLICATION ENTERED
May 4, 2007 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 3, 2007 REPR